GEN Exclusives

More »

GEN News Highlights

More »
Dec 15, 2009

Femta Signs On Lonza to Manufacture Preclinical RA Candidate

  • Femta Pharmaceuticals signed a manufacturing services and license agreement with Lonza for its lead humanized interleukin 6 mAb called FM101. Femta says that it aims to submit an IND for the rheumatoid arthritis candidate in 2010.

    The license deal gives Femta access to Lonza’s GS (glutamine synthetase) Gene Expression System™ as well as cell-line, purification, and process-development expertise to support cGMP process development for the clinical program.



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Using CRISPRs to Tame GMOs

With more climate-induced droughts and insect infestations on the horizon do you think technologies like CRISPR will change a lot of people’s minds about GMOs, including genetically engineered foods?

More »